Neuronal-specific impairment of heparan sulfate degradation in Drosophila reveals pathogenic mechanisms for Mucopolysaccharidosis type IIIADani L. Webber, Louise V. O’Keefe, Amanda Choo et al.|Experimental Neurology|2018Cited by 19
<scp><i>Drosophila melanogaster</i></scp>models of<scp>MPS IIIC</scp>(<scp><i>Hgsnat</i></scp>‐deficiency) highlight the role of glia in disease presentationLaura J. Hewson, Louise V. O’Keefe, Amanda Choo et al.|Journal of Inherited Metabolic Disease|2024Cited by 3
Substrate reduction therapy in a <i>Drosophila melanogaster</i> model of Sanfilippo syndromeSher Li Tan, Adeline A. Lau, Laura J. Hewson et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 1
Substrate reduction using a glucosamine analogue in Drosophila melanogaster and mouse models of Sanfilippo syndromeSher Li Tan, Adeline A. Lau, Daniel Neumann et al.|Molecular Genetics and Metabolism|2025Cited by 0